Journal of General Internal Medicine

, Volume 9, Issue 8, pp 445–449

The ankle—brachial index as a predictor of survival in patients with peripheral vascular disease

  • Mary McGrae McDermott
  • Joe Feinglass
  • Rael Slavensky
  • William H. Pearce
Original Articles

Abstract

Objective: To determine whether the ankle—brachial index (ABI) predicts survival rates among patients with peripheral vascular disease.

Design: A retrospective survival analysis of patients with abnormal ABIs who visited the authors’ blood-flow laboratory during 1987. The National Death Index was used to ascertain survival status for all patients up to January 1, 1992. Kaplan-Meier and Cox proportional hazards analyses were used to determine the relationship between increasing lower-extremity ischemia, measured by ABI, and survival time. Clinical characteristics controlled for included age, smoking history, gender, and comorbidities, as well as the presence of lower-extremity rest pain, ulcer, or gangrene.

Setting: A university hospital blood-flow laboratory.

Patients/participants: Four hundred twenty-two patients who had no prior history of lower-extremity vascular procedures and who had ABIs < 0.92 in 1987.

Results: Cumulative survival probabilities at 52 months’ (4.3 years’) follow-up were 69% for patients who had ABIs =0.5–0.91, 62% for patients who had ABIs =0.31–0.49, and 47% for patients who had ABIs ≤0.3. In multivariate Cox proportional hazard analysis, the relative hazard of death was 1.8 (95% confidence interval =1.2–2.9, p<0.01) for the patients who had ABIs ≤0.3 compared with the patients who had ABIs 0.5–0.91. Other independent predictors of poorer survival included age >65 years (p<0.001); a diagnosis of cancer, renal failure, or chronic lung disease (p<0.001); and congestive heart failure (p<0.04).

Conclusion: The ABI is a powerful tool for predicting survival in patients with peripheral vascular disease. Patients with ABIs ≤ 0.3 have significantly poorer survival than do patients with ABIs 0.31–0.91. Further study is needed to determine whether aggressive coronary risk-factor modification, a work-up for undiagnosed coronary or cerebrovascular atherosclerotic disease, or aggressive therapy for known atherosclerosis can improve survival of patients with ABIs ≤ 0.3.

Key words

peripheral vascular disease survival ankle-brachial index atherosclerosis prediction 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dormandy J, Mahir M, Ascady G, et al. Fate of the patient with chronic leg ischemia. J Cardiovasc Surg. 1989;30:50–7.Google Scholar
  2. 2.
    Hertzer NR, Beven EG, Young JR, et al. Coronary artery disease in peripheral vascular patients—a classification of 1000 coronary angiograms and results of surgical management. Ann Surg. 1984;199:223–33.PubMedCrossRefGoogle Scholar
  3. 3.
    Hughson WG, Mann JI, Tibbs DJ, Woods HF, Walton I. Intermittent claudication: factors determining outcome. Br Med J. 1978;1:1377–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of ten years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality: the Whitehall Study. Circulation. 1990;1925–31.Google Scholar
  6. 6.
    Silbert S, Zazeela H. Prognosis in arteriosclerotic peripheral vascular disease. JAMA. 1958;166:1816–21.Google Scholar
  7. 7.
    Vogt MT, Cauley JA, Newman AB, Kuller LH, Hulley SB. Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA. 1993;270:465–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA. 1993;270:487–9.PubMedCrossRefGoogle Scholar
  9. 9.
    McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119–28.PubMedCrossRefGoogle Scholar
  10. 10.
    Howell MA, Colgan MP, Seeger RW, Ramsey DE, Sumner DS. Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study. J Vasc Surg. 1989;9:691–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Vogt MT, McKenna M, Anderson SJ, Wolfson SK, Kuller LH. The relationship between ankle—arm index and mortality in older men and women. J Am Geriatr Soc. 1993;41:523–30.PubMedGoogle Scholar
  12. 12.
    Wilt TJ. Current strategies in the diagnosis and management of lower extremity peripheral vascular disease. J Gen Intern Med. 1992;2:87–101.Google Scholar
  13. 13.
    Criqui MH, Fronek A, Barrett-Conner E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510–5.PubMedGoogle Scholar
  14. 14.
    Marinelli MR, Beach KW, Glass MJ, Primozich JF, Strandness DE. Noninvasive testing vs. clinical evaluation of arterial disease. A prospective study. JAMA. 1979;241:2031–4.PubMedCrossRefGoogle Scholar

Copyright information

© the Society of General Internal Medicine 1994

Authors and Affiliations

  • Mary McGrae McDermott
    • 1
  • Joe Feinglass
    • 1
    • 3
  • Rael Slavensky
    • 2
  • William H. Pearce
    • 2
  1. 1.the Divisions of General Internal MedicineNorthwestern UniversityChicago
  2. 2.Vascular Surgery, Northwestern University Medical SchoolNorthwestern UniversityChicago
  3. 3.the Center for Health Services and Policy ResearchNorthwestern UniversityChicago
  4. 4.Division of General Internal MedicineChicago

Personalised recommendations